2026 Pharmaceutical Companies Vaccines 
STAT
AUGUST 22, 2023
The Food and Drug Administration approved a Pfizer vaccine that aims to protect newborns against RSV by vaccinating pregnant people, STAT tells us. The vaccine, marketed as Abrysvo, previously won approval for adults over the age of 60. Continue to STAT+ to read the full story…
STAT
JULY 30, 2024
… Four pharmaceutical companies involved in the negotiations over prices for Medicare do not expect a significant impact on their businesses after seeing confidential suggested prices from the government for their drugs that will take effect in 2026 , Reuters writes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JUNE 29, 2022
COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. Sarah Rickwood has 30 years’ experience as a consultant to the pharmaceutical industry. appeared first on.
Viseven
SEPTEMBER 18, 2024
Cloud-based tools allowed pharma companies to capture and share clinical data between research teams both securely and quickly. The rest is history: vaccines were delivered worldwide in record time, saving millions of lives. By the end of 2026, the company will be able to analyze two million genomes.
The Checkup by Singlecare
JUNE 6, 2024
The law will allow Medicare to negotiate directly with pharmaceutical companies to improve access to affordable prescription drug costs. That means a new, negotiated price for Jardiance will be effective in 2026. Ten drugs were selected for the first round of negotiations, and Jardiance was one of them.
ISPE
SEPTEMBER 29, 2023
For more than 240 years, Takeda has focused on delivering transformative treatments in the therapeutic areas of gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines. Takeda has reduced CO2 emission by 861 tons.
The Checkup by Singlecare
JUNE 6, 2024
This law enables Medicare to negotiate directly with pharmaceutical companies, which should ultimately result in lower prescription drug costs for consumers. Farxiga was selected as one of the first 10 drugs for negotiated prices and should be available at lower prices starting in 2026.
Expert insights. Personalized for you.
98 
Let's personalize your content